Skip to main content
Caplight Logo









Amigo

Amigo

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.amigo.ai/

Last Round

Series A

Mar 10, 2026

Total Funding Raised

$17.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Amigo is a healthtech and artificial intelligence company that provides a platform for creating safe, reliable, and transparent AI agents for healthcare organizations.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Patient Engagement, NLP & Conversational AI, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical AI agentspatient engagementEHR integrationelectronic health recordEHRAI agent securityworkflow automationconversational AIclinical scribetelehealth automationpatient intakehealthcare SaaSAI copilotmedical AIclinical workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amigo Comparables

Compare Amigo with similar companies based on industry and business-model similarity.

Amigo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orbita
87%
Sully.ai
84%
Hyro
81%

Amigo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 10, 2026
SeedJan 3, 2025

Key People

Founding team and executive leadership

John Xing

Co-Founder & CTO

Founding Team

Ali Khokhar

Co-founder & CEO

Founding Team

Amigo Investors

Notable investors and investment history

Amigo investors
InvestorRounds
Coho DeeptechSeed
SV AngelSeed
GSV VenturesSeries A, Seed
Optum VenturesSeries A
General CatalystSeries A, Seed
Madrona Venture GroupSeries A
Ride VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 49% MoM to 51.4K.

  • Mar 19, 2026

    Added FAM, a technology/fintech SMB, as a customer.

Amigo Filings

Explore SEC and related filing metadata, where available.

Amigo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amigo's valuation, stock price, and market status.

Is Amigo a public or private company?

Amigo is a private company.

What is the current stock price of Amigo?

Amigo is a private company with no public stock price. No recent secondary market data is available.

How much is Amigo worth (valuation)?

Valuation information for Amigo is not publicly available.

Can I buy Amigo stock?

Amigo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amigo's last funding round?

Amigo's most recent funding round was Series A on March 10, 2026.

Who are the main investors in Amigo?

Key investors in Amigo include GSV Ventures, General Catalyst, Madrona Venture Group, GSV Ventures.

Will Amigo IPO soon?

No public IPO plans have been announced for Amigo.

How can I track Amigo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amigo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range44
Year Founded2024
Last FundingMar 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?